Skip to main content

Lobbying activity

Who's lobbying Congress, for whom, and on what, from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 257 filings

Top spenders & firms Spend by issue Political contributions Revolving door

  Showing filings that named HR 1262. Clear
Clear
Q3
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate
Budget/Appropriations, Copyright/Patent/Trademark, Trade (domestic/foreign), Health Issues
View →
Q3
PTC THERAPEUTICS, INC. for PTC THERAPEUTICS, INC.
3rd Quarter (July 1 - Sep 30) 2025 · New Jersey · House · Senate
Health Issues, Medical/Disease Research/Clinical Labs, Medicare/Medicaid, Taxation/Internal Revenue Code
View →
Q3
AKIN GUMP STRAUSS HAUER & FELD for BIOTECHNOLOGY INNOVATION ORGANIZATION
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $60,000.00 income
Health Issues, Medicare/Medicaid
View →
Q3
LMH STRATEGIC SOLUTIONS for STEALTH BIOTHERAPEUTICS INC.
3rd Quarter (July 1 - Sep 30) 2025 · Massachusetts · House · Senate · $30,000.00 income
Health Issues
View →
Q3
LMH STRATEGIC SOLUTIONS for PTC THERAPEUTICS, INC.
3rd Quarter (July 1 - Sep 30) 2025 · New Jersey · House · Senate · $50,000.00 income
Health Issues
View →
Q3
LMH STRATEGIC SOLUTIONS for IONIS PHARMACEUTICALS, INC.
3rd Quarter (July 1 - Sep 30) 2025 · California · House · Senate · $60,000.00 income
Health Issues
View →
Q3
HARMONY BIOSCIENCES for HARMONY BIOSCIENCES
3rd Quarter (July 1 - Sep 30) 2025 · Pennsylvania · House · Senate
Pharmacy
View →
Q3
ACADIA PHARMACEUTICALS for ACADIA PHARMACEUTICALS
3rd Quarter (July 1 - Sep 30) 2025 · California · House · Senate
Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code
View →
Q3
TWENTY-FIRST CENTURY GROUP, INC. for RAFAEL HOLDINGS, INC.
3rd Quarter (July 1 - Sep 30) 2025 · New Jersey · House · Senate · $24,000.00 income
Health Issues
View →
Q3
TIBER CREEK GROUP for ACADIA PHARMACEUTICALS, INC.
3rd Quarter (July 1 - Sep 30) 2025 · California · House · Senate · $80,000.00 income
Health Issues, Taxation/Internal Revenue Code
View →
Q3
NATIONAL ASSOCIATION OF CHILDRENS HOSPITALS AND AFFILIATES for NATIONAL ASSOCIATION OF CHILDREN'S HOSPITALS (N.A.C.H.)
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate
Education, Health Issues, Medicare/Medicaid, Defense
View →
Q3
MEHLMAN CONSULTING, INC. for ULTRAGENYX PHARMACEUTICAL, INC.
3rd Quarter (July 1 - Sep 30) 2025 · California · House · Senate · $60,000.00 income
Health Issues
View →
Q3
ASTRAZENECA PHARMACEUTICALS LP for ASTRAZENECA PHARMACEUTICALS LP
3rd Quarter (July 1 - Sep 30) 2025 · Delaware · House · Senate
Pharmacy, Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code
View →
Q3
THE KPM GROUP DC LLC for ASTRIA THERAPEUTICS, INC.
3rd Quarter (July 1 - Sep 30) 2025 · Massachusetts · House · Senate · $40,000.00 income
Pharmacy
View →
Q3
ASSOCIATION FOR CLINICAL ONCOLOGY for ASSOCIATION FOR CLINICAL ONCOLOGY
3rd Quarter (July 1 - Sep 30) 2025 · Virginia · House · Senate
Medicare/Medicaid, Health Issues, Tobacco, Budget/Appropriations
View →
Q3
ORCHARD THERAPEUTICS NORTH AMERICA for ORCHARD THERAPEUTICS NORTH AMERICA
3rd Quarter (July 1 - Sep 30) 2025 · Massachusetts · House · Senate
Health Issues, Medicare/Medicaid
View →
Q3
DLA PIPER LLP (US) for BIOTECHNOLOGY INNOVATION ORGANIZATION
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $60,000.00 income
Medical/Disease Research/Clinical Labs, Health Issues, Medicare/Medicaid, Pharmacy
View →
Q3
HEALTHCARE INSTITUTE OF NEW JERSEY for HEALTHCARE INSTITUTE OF NEW JERSEY
3rd Quarter (July 1 - Sep 30) 2025 · New Jersey · House · Senate
Health Issues
View →
Q3
RARE DISEASE COMPANY COALITION for RARE DISEASE COMPANY COALITION
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate
Budget/Appropriations, Pharmacy, Trade (domestic/foreign)
View →
Q3
ROBERTI GLOBAL (FKA ROBERTI WHITE, LLC) for BIOTECHNOLOGY INNOVATION ORGANIZATION (BIO)
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $60,000.00 income
Medicare/Medicaid, Health Issues, Defense
View →
Q3
TRAVERE THERAPEUTICS for TRAVERE THERAPEUTICS
3rd Quarter (July 1 - Sep 30) 2025 · California · House · Senate
Health Issues, Pharmacy, Medical/Disease Research/Clinical Labs, Medicare/Medicaid
View →
Q3
EVERYLIFE FOUNDATION FOR RARE DISEASES for EVERYLIFE FOUNDATION FOR RARE DISEASES
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate
Health Issues
View →
Q3
IONIS PHARMACEUTICALS, INC. for IONIS PHARMACEUTICALS, INC.
3rd Quarter (July 1 - Sep 30) 2025 · California · House · Senate
Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code
View →
Q3
THE KPM GROUP DC LLC for SOLENO THERAPEUTICS, INC.
3rd Quarter (July 1 - Sep 30) 2025 · California · House · Senate · $50,000.00 income
Health Issues
View →
Q3
THE KPM GROUP DC LLC for PRAXIS PRECISION MEDICINES
3rd Quarter (July 1 - Sep 30) 2025 · Massachusetts · House · Senate · $40,000.00 income
Pharmacy
View →
Previous Page 7 of 11 Next

Source: federal Lobbying Disclosure Act filings. A filing's bill references are parsed from its activity descriptions, so a bill page shows the filings that named it.

Report a problem